NCT07416149 Comparing PTeye-assisted Versus Conventional Total Thyroidectomy
| NCT ID | NCT07416149 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The University of Hong Kong |
| Condition | Hypocalcemia |
| Study Type | INTERVENTIONAL |
| Enrollment | 210 participants |
| Start Date | 2025-09-16 |
| Primary Completion | 2028-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 210 participants in total. It began in 2025-09-16 with a primary completion date of 2028-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a prospective, single-blinded, randomized controlled trial to evaluate whether PTeye™ can reduce post-operative hypoparathyroidism (PH). The study will enroll consecutive patients undergoing total thyroidectomy in a teritary endocrine surgery unit in Hong Kong, randomizing them into receiving conventional surgery versus PTeye™-assisted surgery. Subjects will be assigned to the two groups before surgery. Subjects will be under medical care as in usual practice.
Eligibility Criteria
Inclusion Criteria: * Adult patients ≥18 years of age * Undergoing total thyroidectomy, or completion total thyroidectomy * Pre-operative serum adjusted calcium levels within normal ranges Exclusion Criteria: * Patients on pre-operative calcium or vitamin D supplements * Patients with pre-operative vitamin D deficiency, defined as serum vitamin D\<30nmol/L * Patients with untreated primary or secondary hyperparathyroidism * Patient with known non-surgical hypoparathyroidism diseases * Patients with estimated glomerular filtration rate \<30ml/1.73m2/min, on dialysis, or having a history of kidney transplant
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07416149 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hypocalcemia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07416149 currently recruiting?
Yes, NCT07416149 is actively recruiting participants. Contact the research team at mmhfung@hku.hk for enrollment information.
Where is the NCT07416149 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong.
Who is sponsoring the NCT07416149 clinical trial?
NCT07416149 is sponsored by The University of Hong Kong. The trial plans to enroll 210 participants.